Your Part D Drug Plan Costs $0, Medicare Still Bills You Up to $91
A zero-premium Part D plan can still trigger the IRMAA surcharge, adding as much as $91 a month for certain retirees....
During recessions, some index funds fare better than others. This intro highlights selection criteria and defensive positioning.
25,743 articlesA zero-premium Part D plan can still trigger the IRMAA surcharge, adding as much as $91 a month for certain retirees....
Home listings are cooling fast as sellers reset prices. The latest data show a record decline in home asking prices, ...
Grail stock showed a notable bounce after several tough sessions tied to trial updates. This piece breaks down what’s...
A reality TV win can change your life—and your finances—in an instant. This piece examines the financial implications...
Investors brace for potential disruption as Trump-Iran brinkmanship over the Strait of Hormuz raises the risk of oil ...
Barclays lifts Atlassian price target to $112, signaling growing confidence in the company’s ARR trajectory and enter...
New data highlights a tougher entry to the workforce for Gen Z graduates compared with Millennials, with a large shar...
Mecka AI closes a $60 million funding round to train robots using embodied human data from wearables and iPhones, sig...
Retirees aiming for $10,000 a month at 65 face a tight budget once taxes, Medicare premiums, and rising costs are app...
A former chief staff mayor to NYC Mayor Eric Adams has been arrested on bribery and fraud charges, part of a widening...
A Scattered Spider suspect extradited to the US shines a light on how cross-border cybercrime prosecutions unfold. Th...
Amazon's latest earnings highlighted a bold AI bet and a hefty capex agenda. This article breaks down what it means f...